These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure. Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900 [TBL] [Abstract][Full Text] [Related]
23. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814 [TBL] [Abstract][Full Text] [Related]
24. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959 [TBL] [Abstract][Full Text] [Related]
25. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA Clin Transpl; 2011; ():351-8. PubMed ID: 22755430 [TBL] [Abstract][Full Text] [Related]
26. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients. Lee KW; Park JB; Cho CW; Lee N; Yoo H; Kim K; Park H; Kang ES; Huh W; Kim S Ann Transplant; 2017 Mar; 22():166-176. PubMed ID: 28348361 [TBL] [Abstract][Full Text] [Related]
27. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534 [TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients. Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147 [TBL] [Abstract][Full Text] [Related]
29. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection. Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439 [TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation. Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330 [TBL] [Abstract][Full Text] [Related]
31. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
37. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations. Dieplinger G; Ditt V; Arns W; Huppertz A; Kisner T; Hellmich M; Bauerfeind U; Stippel DL Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087 [TBL] [Abstract][Full Text] [Related]
38. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection. Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746 [TBL] [Abstract][Full Text] [Related]
39. Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort. Gautier Vargas G; Olagne J; Parissiadis A; Joly M; Cognard N; Perrin P; Froelich N; Guntz P; Gachet C; Moulin B; Caillard S Transplantation; 2020 Oct; 104(10):2148-2157. PubMed ID: 31895344 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Yamada C; Ramon DS; Cascalho M; Sung RS; Leichtman AB; Samaniego M; Davenport RD Transfusion; 2015 Apr; 55(4):727-35; quiz 726. PubMed ID: 25385678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]